Serum Fetuin-A, Cardiovascular Risk Factors, and Six-Year Follow-up Outcome in Patients With Coronary Heart Disease

American Journal of Cardiology

Volumn 105, Issue 12, 2010, Pages 1666-1672

  Roos, Marcel ^a   von Eynatten, Maximilian ^a   Heemann, Uwe ^a   Rothenbacher, Dietrich ^b   Brenner, Hermann ^b   Breitling, Lutz P ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FETUIN A; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PROTEINS; BRAIN ISCHEMIA; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 77953122859     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.01.342     Document Type: Article

References (19)

1. Wang H., Zhang M., Bianchi M., Sherry B., Sama A., and Tracey K.J. Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophage deactivating molecules. Proc Natl Acad Sci U S A 95 (1998) 14429-14434
2. Ketteler M., Bongartz P., Westenfeld R., Wildberger J.E., Mahnken A.H., Böhm R., Metzger T., Wanner C., Jahnan-Dechent W., and Floege J. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361 (2003) 827-833
3. Weikert C., Stefan N., Schulze M.B., Pischon T., Berger K., Joost H.G., Häring H.U., Boeing H., and Fritsche A. Plasma fetuin-A levels and the risk of myocardial infarction and ischemic stroke. Circulation 118 (2008) 2555-2562
4. Stefan N., Hennige A., Staiger H., Machann J., Schick F., Kröber S., Machica F., Fritsche A., and Häring H.U. Alpha 2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the Liver in humans. Diabetes Care 29 (2006) 853-857
5. Mori K., Emoto M., Yokoyama H., Araki T., Teramura M., Koyama H., Shoji T., Inaba M., and Nishizawa Y. Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care 29 (2006) 468
6. Ix J.H., Shlipak M.G., Brandenburg V.M., Ali S., Ketteler M., and Whooley M.A. Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 113 (2006) 1760-1767
7. Rothenbacher D., Koenig W., and Brenner H. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease. Arch Intern Med 166 (2006) 2455-2460
8. Küpper-Nybelen J., Rothenbacher D., Hahmann H., Wüsten B., and Brenner H. Changes of risk factors in patients with coronary heart disease after in-patient rehabilitation. Dtsch Med Wochenschr 128 (2003) 1525-1530
9. Twardella D., Küpper-Nybelen J., Rothenbacher D., Hahmann H., Wüsten B., and Brenner H. Short-term benefit of smoking cessation in patients with coronary heart disease: estimates based on self-reported smoking data and serum cotinine measurements. Eur Heart J 25 (2004) 2101-2108
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
11. Ix J.H., Wassel C.L., Kanaya A.M., Vittinghoff E., Johnson K.C., Koster A., Cauley J.A., Harris T.B., Cummings S.R., and Shlipak M.G. Fetuin-A and incident diabetes mellitus in older persons. Health ABC Study. JAMA 300 (2008) 182-188
12. Mehrotra R., Westenfeld R., Christenson P., Budoff M., Ipp E., Takasu J., Gupta A., Norris K., Ketteler M., and Adler S. Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int 67 (2005) 1070-1077
13. Lebreton J.P., Joisel F., Raoult J.P., Lannuzel B., Rogez J.P., and Humbert G. Serum concentration of human α2HS glycoprotein during inflammatory process. Evidence that α2HS glycoprotein is a negative acute-phase reactant. J Clin Invest 64 (1979) 1118-1129
14. Lim P., Collet J.P., Moutereau S., Guigui N., Mitchell-Heggs L., Loric S., Bernard M., Benhamed S., Montalescot G., Randé J.L., and Guéret P. Fetuin-A is an independent predictor of death after ST-elevation myocardial infarction. Clin Chem 53 (2007) 1835-1840
15. Merx M.W., Schäfer C., Westenfeld R., Brandenburg V., Hidajat S., Weber C., Ketteler M., and Jahnen-Dechent W. Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice. J Am Soc Nephrol 16 (2005) 3357-3364
16. Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., Lowe G.D., Pepys M.B., and Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
17. von Eynatten M., Hamann A., Twardella D., Nawroth P.P., Brenner H., and Rothenbacher D. Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease. Eur Heart J 29 (2008) 1307-1315
18. Reinehr T., and Roth C.L. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab 93 (2008) 4479-4485
19. Stefan N., Hennige A.M., Staiger H., Machann J., Schick F., Kröber S.M., Machicao F., Fritsche A., and Häring H.U. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29 (2006) 853-857